Literature DB >> 22237138

Clinical characteristics and outcome of apical ballooning syndrome in Auckland, New Zealand.

Jen-Li Looi1, Chi-Wing Wong, Ali Khan, Mark Webster, Andrew J Kerr.   

Abstract

BACKGROUND: Apical ballooning syndrome (ABS) mimics myocardial infarction but is characterised by transient left ventricular (LV) dysfunction without significant coronary artery obstruction.
METHODS: We prospectively identified 100 consecutive patients presenting in the Auckland region between March 2004 and July 2010 and obtained clinical, laboratory, electrocardiography, echocardiography, coronary angiography and long-term follow-up data.
RESULTS: Chest pain or dyspnoea were the most common presenting symptom, 95% were women (mean age 65 ± 11 years). An associated stressor was identified in two-thirds of patients, troponin was elevated in all patients, and one-third had ECG ST-elevation. There was a similar range of initial LV ejection fraction (EF), myocardial damage, LV recovery and prognosis in those with and without ST-elevation, and with and without identifiable stressors. One-quarter had a complicated in-hospital course. Lower admission LVEF, but not peak troponin level or ECG ST-elevation, was associated with a complicated in-hospital course. The mean follow-up was 3.0 ± 1.7 years. One patient died in hospital. Four died late after discharge, all from non-cardiac causes. Seven had recurrent ABS.
CONCLUSION: In this large, prospective, New Zealand ABS cohort a quarter of patients had a complicated in-hospital course, but almost all recovered, recurrence was infrequent and long-term prognosis dependent on associated non-cardiac disease. Copyright Â
© 2012 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22237138     DOI: 10.1016/j.hlc.2011.11.010

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  9 in total

Review 1.  Epidemiology and natural history of recovery of left ventricular function in recent onset dilated cardiomyopathies.

Authors:  Michael M Givertz; Douglas L Mann
Journal:  Curr Heart Fail Rep       Date:  2013-12

Review 2.  Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future.

Authors:  Farah Omran; Ioannis Kyrou; Faizel Osman; Ven Gee Lim; Harpal Singh Randeva; Kamaljit Chatha
Journal:  Int J Mol Sci       Date:  2022-05-19       Impact factor: 6.208

3.  In-hospital and long-term mortality in Takotsubo cardiomyopathy: a community hospital experience.

Authors:  Olga Vriz; Gabriele Brosolo; Stefano Martina; Franco Pertoldi; Rodolfo Citro; Lucio Mos; Francesco Ferrara; Eduardo Bossone
Journal:  J Community Hosp Intern Med Perspect       Date:  2016-07-06

4.  Symptoms in patients with takotsubo syndrome: a qualitative interview study.

Authors:  Sara Wallström; Kerstin Ulin; Elmir Omerovic; Inger Ekman
Journal:  BMJ Open       Date:  2016-10-05       Impact factor: 2.692

5.  Postdischarge outcome after Takotsubo syndrome compared with patients post-ACS and those without prior CVD: ANZACS-QI 19.

Authors:  Jen-Li Looi; Mildred Lee; Mark W I Webster; Andrew C Y To; Andrew J Kerr
Journal:  Open Heart       Date:  2018-11-26

6.  Incidence and Clinical Impact of Recurrent Takotsubo Syndrome: Results From the GEIST Registry.

Authors:  Ibrahim El-Battrawy; Francesco Santoro; Thomas Stiermaier; Christian Möller; Francesca Guastafierro; Giuseppina Novo; Salvatore Novo; Enrica Mariano; Francesco Romeo; Fabiana Romeo; Holger Thiele; Federico Guerra; Alessandro Capucci; Irene Giannini; Natale Daniele Brunetti; Ingo Eitel; Ibrahim Akin
Journal:  J Am Heart Assoc       Date:  2019-05-07       Impact factor: 5.501

7.  A case report of recurrent takotsubo cardiomyopathy including the rare 'inverted' form.

Authors:  Charles Carey; Gaetano Nucifora; Anita Macnab
Journal:  Eur Heart J Case Rep       Date:  2022-05-20

8.  Takotsubo Cardiomyopathy: A Long Term Follow-up Shows Benefit with Risk Factor Reduction.

Authors:  Koroush Khalighi; Mohammad Umar Farooq; Thein Tun Aung; Swe Oo
Journal:  J Cardiovasc Dev Dis       Date:  2015-11-16

9.  Factors Associated with Recurrence in Takotsubo Syndrome: A Systematic Review.

Authors:  Felipe Alverenga Duarte Campos; Luiz Eduardo Fonteles Ritt; João Paulo Soares Costa; Constança Margarida Cruz; Gilson Soares Feitosa-Filho; Queila Borges de Oliveira; Eduardo Sahade Darzé
Journal:  Arq Bras Cardiol       Date:  2020-03       Impact factor: 2.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.